Emcure Pharmaceuticals Ltd.
EMCURE
Rang in aandelen
#4333
Emcure Pharmaceuticals Limited is committed to providing high-quality,... Emcure Pharmaceuticals Limited is committed to providing high-quality, cost-effective healthcare solutions to a global market. The company boasts a diverse product lineup spanning numerous medical fields, such as women's health (gynecology), anti-infectives, pain relief, nutritional supplements (vitamins, minerals, and nutrients), hematology, oncology, respiratory treatments, HIV antivirals, gastrointestinal remedies, anti-diabetics, neurological medications, and cardiovascular therapies. Notable brand names under their umbrella include Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym. Founded in 1981, Emcure Pharmaceuticals Limited is headquartered in Pune, India.
Aandeelprijs
$18.81
Marktkapitalisatie
$3.57B
Verandering (1 dag)
-3.13%
Verandering (1 jaar)
18.91%
Land
IN
Handel Emcure Pharmaceuticals Ltd. (EMCURE)
Categorie
Healthcare
Koersgeschiedenis voor Emcure Pharmaceuticals Ltd. (EMCURE)
Hoogste slotkoers: $20.40 op 2026-10-01
Laagste slotkoers: $15.91 op 2024-07-01
Laagste slotkoers: $15.91 op 2024-07-01
Koersgeschiedenis van Emcure Pharmaceuticals Ltd. van 2024 tot 2026
Jaarlijkse koersprestatie
| Jaar | Prestaties |
|---|---|
| 2026 (TTM) | 16.96% |
| 2025 | -4.84% |
| 2024 | 0.00% |
Aandelenkoers van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aandelenkoers | Verandering 1jr% | Land |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
